Home/Filings/4/0001415889-23-005044
4//SEC Filing

GRAHAM RICHARD A 4

Accession 0001415889-23-005044

CIK 0001583107other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 7:04 PM ET

Size

4.7 KB

Accession

0001415889-23-005044

Insider Transaction Report

Form 4
Period: 2023-03-14
GRAHAM RICHARD A
SVP, Development
Transactions
  • Sale

    Ordinary Shares

    2023-03-14$10.32/sh2,323$23,973371,817 total
Footnotes (1)
  • [F1]This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001820036

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 7:04 PM ET
Size
4.7 KB